Aktiespot

BioAdaptives, Inc. (Bioadaptives, Inc.) Aktie

BDPT

$0.0056-0.0004 (-6.67%)
Chart wird geladen...
Bioadaptives, Inc. Logo

Bioadaptives, Inc.

Eröffnung0.0060
Hoch0.0060
Tief0.0057
Volumen329.28k
P/EN/A
Marktkapitalisierung67.25k
52-Wochen-Hoch0.0900
52-Wochen-Tief0.0050
Durchschn. Volumen51.99k
DividendeN/A
BetaN/A
EPS-0.1400

Über BioAdaptives, Inc. (Bioadaptives, Inc.) Aktie

BioAdaptives, Inc. investigates, markets, and distributes natural plant, fungi, and algal-based products and medical devices for humans and animals. The company offers MyndMed for immediate cognitive enhancement, medium-term resilience and memory gains, and long-term neuroprotection and cognitive health; Zeranovia, a weight loss enhancer; Wynovia to help reduce the loss of lean muscle mass during dieting; and Xcellara, a regenerative wellness solution. It also provides canine products under the PawPa brand; dog chew products under the Regen brand; and Lung Flute, a medical device. The company was formerly known as APEX 8 Inc. and changed its name to BioAdaptives, Inc. in September 2013. BioAdaptives, Inc. was incorporated in 2013 and is based in Las Vegas, Nevada.

Unternehmensinformationen

Börse: OTC Markets OTCPK (PNK)
Sektor: Stabile forbrugsvarer
Branche: Forarbejdede og pakkede fødevarer
Adresse:
2620 Regatta Drive
89128 Las Vegas, United States
Telefon: + 702 659 8829

Analystenempfehlungen

Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.

Niedrigstes Kursziel
Durchschnittliches Kursziel
Median Kursziel
Höchstes Kursziel

Andere sehen auch: